Schaeffer's Top Stock Picks for '25

The Drug Stock Down 60% After FDA Rejection

ACRX stock has gone from an annual high Wednesday to within pennies of an annual low

Managing Editor
Oct 12, 2017 at 10:05 AM
facebook X logo linkedin


U.S. stocks are trading slightly lower this morning, as third-quarter earnings season commences. Among the stocks making moves this morning are banking institution and blue-chip powerhouse JPMorgan Chase & Co (NYSE:JPM), pizza restaurant chain Domino's Pizza, Inc. (NYSE:DPZ), and drugmaker AcelRx Pharmaceuticals Inc (NASDAQ:ACRX). Here's a closer look at what's moving shares of JPM, DPZ, and ACRX.

JPMorgan Stock Dips After Earnings

While JPMorgan Chase reported better-than-expected third-quarter earnings, the bank's bond trading revenue was weaker than forecast. The blue-chip stock was last seen trading fractionally lower at $96.67, likely to the dismay of recent options traders. JPM's Schaeffer's put/call open interest ratio (SOIR) of 0.66 ranks in only the 7th percentile of its annual range, which suggests that near-term options traders have rarely been more call biased in the past 12 months. Still, JPM stock has added more than 12% in 2017, and touched a record high of $97.64 on Oct. 6.

DPZ Stock Takes a Breather After Same-Store Sales Miss

Shares of Domino's Pizza have dipped 2.4% to $204.20, but seem to have found support at their 10-day and 20-day moving averages. While the pizza company reported better-than-expected third-quarter earnings, same-store sales growth fell short of expectations. Prior to today, Domino's stock had been on a tear, rallying roughly 20% from its August lows amid a sea of skepticism. Just five of 15 analysts consider DPZ stock worthy of a "buy" or better rating, leaving the door wide open for upgrades if the equity resumes its recent ascent.

ACRX Stock Flatlines After FDA Rejection

ACRX shares have taken a major hit after the Food and Drug Administration (FDA) rejected the firm's opioid painkiller, Dsuvia. Just one day after touching an annual high of $5.75, the drug stock was last seen 60% lower at $2.15 -- within pennies of a new low. Some recent option buyers are likely cheering the news. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), ACRX sports a 50-day put/call volume ratio of 0.43, ranking in the 94th percentile of its annual range, suggesting options traders have bought to open puts over calls at a faster-than-usual clip during the past 10 weeks.
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter